APOE and Alzheimer disease: In addition to providing support for the antagonistic pleiotropy hypothesis, this investigation documents changes in STM that occur with healthy ageing, and thereby provides a comprehensive profile of STM performance in APOE ε4 gene carriers and non-carriers, on a large-scale, that will aid in delineating cognitive markers associated with AD-related pathology, compared to non-AD related effects of this gene.